Open0.740 | Close0.719 |
Vol / Avg.157.016K / 225.089K | Mkt Cap12.702M |
Day Range0.670 - 0.799 | 52 Wk Range0.425 - 2.780 |
AcelRx Pharmaceuticals Stock (NASDAQ: ACRX) stock price, news, charts, stock research, profile.
Open0.740 | Close0.719 |
Vol / Avg.157.016K / 225.089K | Mkt Cap12.702M |
Day Range0.670 - 0.799 | 52 Wk Range0.425 - 2.780 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.280 | -0.080 | 0.2000 | ||||
REV | 130.000K | 117.000K | -13.000K |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.530 | -0.400 | 0.1300 | ||||
REV | 70.000K | 253.000K | 183.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-10-02 | Alliance Global Partners | James Molloy | Initiates Coverage On | Buy | Announces | - | 4.25 |
2023-09-25 | HC Wainwright & Co. | Ed Arce | Maintains | BuyBuy | Lowers | 8.00 | 5.00 |
2023-08-18 | HC Wainwright & Co. | Ed Arce | Upgrades | NeutralBuy | Announces | - | 8.00 |
2022-03-14 | HC Wainwright & Co. | Ed Arce | Downgrades | BuyNeutral | - | - | - |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ACRX | AcelRx Pharmaceuticals | 1.26% | 12.7M |
CING | Cingulate | -7.89% | 5.9M |
COCP | Cocrystal Pharma | 8.19% | 18.8M |
ONTX | Onconova Therapeutics | -1.49% | 13.9M |
JAGX | Jaguar Health | 0.06% | 17.8M |
You can purchase shares of AcelRx Pharmaceuticals (NASDAQ: ACRX) through any online brokerage.
Other companies in AcelRx Pharmaceuticals’s space includes: Cingulate (NASDAQ:CING), Cocrystal Pharma (NASDAQ:COCP), Onconova Therapeutics (NASDAQ:ONTX), Jaguar Health (NASDAQ:JAGX) and Palisade Bio (NASDAQ:PALI).
The latest price target for AcelRx Pharmaceuticals (NASDAQ: ACRX) was reported by Alliance Global Partners on Monday, October 2, 2023. The analyst firm set a price target for 4.25 expecting ACRX to rise to within 12 months (a possible 467.20% upside). 3 analyst firms have reported ratings in the last year.
The stock price for AcelRx Pharmaceuticals (NASDAQ: ACRX) is $0.7493 last updated Today at November 28, 2023 at 10:24 PM UTC.
There is no dividend information for AcelRx Pharmaceuticals.
AcelRx Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for AcelRx Pharmaceuticals.
AcelRx Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.